---
title: "Recent Advances in unravelling the genetic Basis and causal pathways of Type 2 Diabetes:"
subtitle: "A scoping review of Mendelian Randomization Studie"
author: "Mahdi Akbarzadeh, Melika Golmohammadi, Nima Babaei Darzi, Tara Asadi, Avin Khalichi, Reyhaneh Banaei Mobarak Abadi, Samin Mohammadi Farsani, Danial Habibi, Maryam Zarkesh, Maryam Sanoie, Amin Farahani, Mahdi Safarpoor, Farzad Hadaegh, Fereidoun Azizi, Mehdi Hedayati, Maryam Sadat Daneshpour"
site: bookdown::bookdown_site
documentclass: book
output:
  bookdown::bs4_book:
    theme:
      bootswatch: flatly     # یا cerulean, yeti, lumen, cosmo, minty...
    toc: true
    toc_depth: 3
    repo: https://github.com/username/repo  # اختیاری
---


<center>

<h1 style="font-size:2.3em; font-weight:bold; margin-bottom:0.2em;">
Recent Advances in unravelling the genetic Basis and causal pathways of Type 2 Diabetes: A scoping review of Mendelian Randomization Studie 
</h1>

<h2 style="font-size:1.4em; font-style:italic; margin-top:0;">
Causal Insights into Type 2 Diabetes from Mendelian Randomization
</h2>

<h3 style="margin-top:0.5em; font-weight:normal;">
Short Title: <b style="color:#6b4ef7;">Causal Insights into Type 2 Diabetes</b>
</h3>

<br>

<h3 style="font-weight:bold; margin-bottom:0.3em;">Authors:</h3>

<p style="font-size:1.05em; line-height:1.6em;">
Mahdi Akbarzadeh<sup>1</sup>, Melika Golmohammadi<sup>2,3</sup>, Nima Babaei Darzi<sup>2</sup>, Tara Asadi<sup>2</sup>, Avin Khalichi<sup>2</sup>, Reyhaneh Banaei Mobarak Abadi<sup>2</sup>, Samin Mohammadi Farsani<sup>2</sup>, Danial Habibi<sup>4</sup>, Maryam Zarkesh<sup>1</sup>, Maryam Sanoie<sup>1</sup>, Amin Farahani<sup>1</sup>, Mahdi Safarpoor<sup>5</sup>, Farzad Hadaegh<sup>3</sup>, Fereidoun Azizi<sup>6</sup>, Mehdi Hedayati<sup>1</sup>, Maryam Sadat Daneshpour<sup>1</sup>
</p>

<br>

<h4 style="font-weight:bold;">Affiliations:</h4>

<p style="font-size:0.95em; text-align:left; display:inline-block; margin: 0 auto;">
1. Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Molecular Biology, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br>
2. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br>
3. Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br>
4. Department of Epidemiology and Biostatistics, School of Public Health, Babol University of Medical Sciences, Babol, Iran.<br>
5. Global Health Institute (GHI), Family Medicine and Population Health Department (FAMPOP), Faculty of Medicine, University of Antwerp, Antwerp, Belgium.<br>
6. Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
</p>

<br><br>
<p><b>Corresponding author:</b> Mahdi Akbarzadeh — <a href="mailto:akbarzadeh.ms@gmail.com">akbarzadeh.ms@gmail.com</a></p>

<br>
<p><i>October 2025</i></p>

</center>

---

# About This Book

This electronic book provides a structured and interactive synthesis of existing Mendelian Randomization (MR) studies examining the causal relationships between **Type 2 Diabetes Mellitus (T2DM)** and its multisystem complications.  
Rather than performing new computational analyses, the purpose of this work is to **map, organize, and critically appraise the existing MR evidence** across various organ systems.

The book is designed to:
- Summarize published MR findings related to T2DM risk factors and outcomes;  
- Evaluate the strength, consistency, and limitations of causal evidence;  
- Offer readers an accessible, reproducible, and visually guided exploration of T2DM’s causal landscape;  
- Identify methodological patterns and knowledge gaps that inform future research directions.

---

# Introduction

Type 2 diabetes mellitus (T2DM) is a chronic and heterogeneous metabolic disorder characterized by hyperglycemia resulting from impaired insulin secretion, insulin resistance, or both. Beyond glycemic control, T2DM exerts systemic effects across nearly every physiological domain—metabolic, cardiovascular, renal, hepatic, neurological, musculoskeletal, immune, and reproductive—leading to a broad spectrum of comorbidities. Globally, the prevalence of T2DM continues to rise, affecting more than half a billion adults and imposing an immense clinical and socioeconomic burden on health systems worldwide.

While epidemiological research has long identified associations between T2DM and a wide range of diseases, these associations are often confounded by shared risk factors such as obesity, diet, and lifestyle, as well as by reverse causation. Disentangling these complex relationships is essential to determine whether T2DM itself causally contributes to secondary disorders, or whether both share common biological pathways.

**Mendelian randomization (MR)** provides an innovative framework to strengthen causal inference in this context. By using germline genetic variants as instrumental variables, MR can approximate the effect of a modifiable exposure—such as T2DM liability, insulin resistance, or hyperglycemia—on diverse health outcomes. Because genetic variants are randomly assorted at conception, MR is less susceptible to confounding and temporal ambiguity, offering a quasi-experimental approach to understanding disease causality.

Over the past decade, MR studies have rapidly expanded in both scope and resolution, exploring the *bidirectional* causal interplay between T2DM and a wide variety of disorders across organ systems. However, these studies are dispersed across multiple domains, vary in analytical design, and often yield inconsistent findings. Synthesizing this evidence is crucial to map the broader network of causal relationships that link T2DM with systemic health outcomes.

This **scoping review** systematically organizes and interprets existing MR evidence connecting T2DM with biological systems and disease categories. Each chapter of this book corresponds to a specific physiological or pathological domain, enabling a comprehensive yet structured exploration of the causal landscape. The thematic sections include:

- **S1–S2:** Nutritional status and factors influencing health or healthcare contact  
- **S3–S4:** Endocrine disorders and metabolic intermediates  
- **S5–S7:** Circulatory, musculoskeletal, and neurological disorders  
- **S8–S10:** Mental, behavioural, neurodevelopmental, digestive, and visual system disorders  
- **S11–S13:** Neoplasms, respiratory, and sexual health disorders  
- **S14–S16:** Infectious, sleep-related, and perinatal conditions  
- **S17–S18:** Genitourinary and immune system disorders  
- **S19–S21:** Developmental anomalies, pregnancy-related conditions, and skin disorders  

Within each domain, the review synthesizes MR findings to highlight consistent causal pathways, conflicting results, and areas of uncertainty. Together, these sections provide a panoramic view of how genetic predisposition to T2DM—and its metabolic correlates—interacts with diverse physiological systems.

The overarching aim of this book is not to generate new analyses but to integrate, contextualize, and critically evaluate the expanding body of MR literature on T2DM. By aligning evidence from multiple disease systems, this review seeks to:

1. Map the scope and diversity of MR findings related to T2DM;  
2. Identify robust causal associations and unresolved inconsistencies;  
3. Evaluate methodological quality, bias sources, and analytical limitations;  
4. Provide an accessible, system-level synthesis to guide future research and clinical translation.

Ultimately, this work offers a structured and comprehensive overview of the causal links between T2DM and multisystem disorders, bridging epidemiological genetics with clinical insight and highlighting the interconnected nature of metabolic disease.
